PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance

Hypertriglyceridemia is an important risk factor associated with insulin resistance and β-cell dysfunction. This study investigated the effects of hypertriglyceridemia and fenofibrate treatment on insulin sensitivity and β-cell function in subjects with normal glucose tolerance. A total of 1974 subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Lu, Rui, Wang, Ying, Hu, Yanjin, Jia, Yumei, Yang, Ning, Fu, Jing, Wang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789521/
https://www.ncbi.nlm.nih.gov/pubmed/27034649
http://dx.doi.org/10.1155/2016/6232036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789521/
https://www.ncbi.nlm.nih.gov/pubmed/27034649
http://dx.doi.org/10.1155/2016/6232036

Ejemplares similares